254 related articles for article (PubMed ID: 15496400)
21. Tumor suppressor CYLD regulates JNK-induced cell death in Drosophila.
Xue L; Igaki T; Kuranaga E; Kanda H; Miura M; Xu T
Dev Cell; 2007 Sep; 13(3):446-54. PubMed ID: 17765686
[TBL] [Abstract][Full Text] [Related]
22. Role of nuclear factor-kappa B and mitogen-activated protein kinase signaling pathways in IL-1 beta-mediated induction of alpha-PDGF receptor expression in rat pulmonary myofibroblasts.
Lindroos PM; Rice AB; Wang YZ; Bonner JC
J Immunol; 1998 Oct; 161(7):3464-8. PubMed ID: 9759865
[TBL] [Abstract][Full Text] [Related]
23. Differential requirement of IKK2 for CYLD-dependent representation of thymic and peripheral T-cell populations.
Tsagaratou A; Grammenoudi S; Mosialos G
Eur J Immunol; 2011 Oct; 41(10):3054-62. PubMed ID: 21728169
[TBL] [Abstract][Full Text] [Related]
24. The E3 ubiquitin ligase MIB2 enhances inflammation by degrading the deubiquitinating enzyme CYLD.
Uematsu A; Kido K; Takahashi H; Takahashi C; Yanagihara Y; Saeki N; Yoshida S; Maekawa M; Honda M; Kai T; Shimizu K; Higashiyama S; Imai Y; Tokunaga F; Sawasaki T
J Biol Chem; 2019 Sep; 294(38):14135-14148. PubMed ID: 31366726
[TBL] [Abstract][Full Text] [Related]
25. Loss of CYLD might be associated with development of salivary gland tumors.
Fukuda M; Hiroi M; Suzuki S; Ohmori Y; Sakashita H
Oncol Rep; 2008 Jun; 19(6):1421-7. PubMed ID: 18497946
[TBL] [Abstract][Full Text] [Related]
26. TRAF6 is required for TRAF2-dependent CD40 signal transduction in nonhemopoietic cells.
Davies CC; Mak TW; Young LS; Eliopoulos AG
Mol Cell Biol; 2005 Nov; 25(22):9806-19. PubMed ID: 16260598
[TBL] [Abstract][Full Text] [Related]
27. Ebselen inhibits tumor necrosis factor-alpha-induced c-Jun N-terminal kinase activation and adhesion molecule expression in endothelial cells.
Yoshizumi M; Fujita Y; Izawa Y; Suzaki Y; Kyaw M; Ali N; Tsuchiya K; Kagami S; Yano S; Sone S; Tamaki T
Exp Cell Res; 2004 Jan; 292(1):1-10. PubMed ID: 14720501
[TBL] [Abstract][Full Text] [Related]
28. CYLD inhibits melanoma growth and progression through suppression of the JNK/AP-1 and β1-integrin signaling pathways.
Ke H; Augustine CK; Gandham VD; Jin JY; Tyler DS; Akiyama SK; Hall RP; Zhang JY
J Invest Dermatol; 2013 Jan; 133(1):221-9. PubMed ID: 22832488
[TBL] [Abstract][Full Text] [Related]
29. Linking JNK signaling to NF-kappaB: a key to survival.
Papa S; Zazzeroni F; Pham CG; Bubici C; Franzoso G
J Cell Sci; 2004 Oct; 117(Pt 22):5197-208. PubMed ID: 15483317
[TBL] [Abstract][Full Text] [Related]
30. Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma.
Annunziata CM; Davis RE; Demchenko Y; Bellamy W; Gabrea A; Zhan F; Lenz G; Hanamura I; Wright G; Xiao W; Dave S; Hurt EM; Tan B; Zhao H; Stephens O; Santra M; Williams DR; Dang L; Barlogie B; Shaughnessy JD; Kuehl WM; Staudt LM
Cancer Cell; 2007 Aug; 12(2):115-30. PubMed ID: 17692804
[TBL] [Abstract][Full Text] [Related]
31. Tanshinone IIA inhibits LPS-induced NF-kappaB activation in RAW 264.7 cells: possible involvement of the NIK-IKK, ERK1/2, p38 and JNK pathways.
Jang SI; Kim HJ; Kim YJ; Jeong SI; You YO
Eur J Pharmacol; 2006 Aug; 542(1-3):1-7. PubMed ID: 16797002
[TBL] [Abstract][Full Text] [Related]
32. Ubiquitin signalling in the NF-kappaB pathway.
Chen ZJ
Nat Cell Biol; 2005 Aug; 7(8):758-65. PubMed ID: 16056267
[TBL] [Abstract][Full Text] [Related]
33. Subquinocin, a small molecule inhibitor of CYLD and USP-family deubiquitinating enzymes, promotes NF-κB signaling.
Yamanaka S; Sato Y; Oikawa D; Goto E; Fukai S; Tokunaga F; Takahashi H; Sawasaki T
Biochem Biophys Res Commun; 2020 Mar; 524(1):1-7. PubMed ID: 31898971
[TBL] [Abstract][Full Text] [Related]
34. Calcium/calmodulin-dependent kinase II is required for platelet-activating factor priming.
Cuschieri J; Bulger E; Garcia I; Jelacic S; Maier RV
Shock; 2005 Feb; 23(2):99-106. PubMed ID: 15665723
[TBL] [Abstract][Full Text] [Related]
35. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
[TBL] [Abstract][Full Text] [Related]
36. Tumor suppressor CYLD: negative regulation of NF-kappaB signaling and more.
Courtois G
Cell Mol Life Sci; 2008 Apr; 65(7-8):1123-32. PubMed ID: 18193168
[TBL] [Abstract][Full Text] [Related]
37. Genetic deletion of PKR abrogates TNF-induced activation of IkappaBalpha kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation.
Takada Y; Ichikawa H; Pataer A; Swisher S; Aggarwal BB
Oncogene; 2007 Feb; 26(8):1201-12. PubMed ID: 16924232
[TBL] [Abstract][Full Text] [Related]
38. MEK kinase 1 is critically required for c-Jun N-terminal kinase activation by proinflammatory stimuli and growth factor-induced cell migration.
Xia Y; Makris C; Su B; Li E; Yang J; Nemerow GR; Karin M
Proc Natl Acad Sci U S A; 2000 May; 97(10):5243-8. PubMed ID: 10805784
[TBL] [Abstract][Full Text] [Related]
39. The role of the death-domain kinase RIP in tumour-necrosis-factor-induced activation of mitogen-activated protein kinases.
Devin A; Lin Y; Liu ZG
EMBO Rep; 2003 Jun; 4(6):623-7. PubMed ID: 12776182
[TBL] [Abstract][Full Text] [Related]
40. Ser/Thr protein phosphatase 5 inactivates hypoxia-induced activation of an apoptosis signal-regulating kinase 1/MKK-4/JNK signaling cascade.
Zhou G; Golden T; Aragon IV; Honkanen RE
J Biol Chem; 2004 Nov; 279(45):46595-605. PubMed ID: 15328343
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
